| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/12/2001 | WO2000055318A8 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 07/12/2001 | WO2000034447A8 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 07/12/2001 | WO2000032750A9 Transgenic circulating endothelial cells |
| 07/12/2001 | US20010008025 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
| 07/12/2001 | US20010007860 Immunology response |
| 07/12/2001 | US20010007771 Cationic polymers and lipids for the delivery of nucleic acids |
| 07/12/2001 | US20010007767 Genetic engineering |
| 07/12/2001 | US20010007659 Use of lentiviral vectors for antigen presentation in dendritic cells |
| 07/12/2001 | US20010007656 Introducing cells treated in vivo with DNA segment comprising transcription factor gene (c-Myc) and operably linked promoter sequence to patient |
| 07/12/2001 | CA2396779A1 Gene therapy to promote angiogenesis and/or the treatment of heart failure |
| 07/12/2001 | CA2396401A1 Novel fgf homolog zfgf12 |
| 07/12/2001 | CA2396040A1 Novel bacterial genes and proteins that are essential for cell viability and their uses |
| 07/12/2001 | CA2395876A1 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | CA2395742A1 Compositions comprising nucleic acids incorporated in bilaminar mineral particles |
| 07/12/2001 | CA2395636A1 Novel colloid synthetic vectors for gene therapy |
| 07/11/2001 | EP1114862A2 Use of polyeptides or their encoding nucleic acids for the diagnosis or treatment of skin diseases and their use in indentifying pharmacologically acitve substances |
| 07/11/2001 | EP1114861A1 Ly6h gene |
| 07/11/2001 | EP1114189A1 Recombinant newcastle disease virus rna expression systems and vaccines |
| 07/11/2001 | EP1114172A1 Transfer method for specific cellular localisation of nucleic acids |
| 07/11/2001 | EP1114171A1 Methods for treatment of degenerative retinal diseases |
| 07/11/2001 | EP1114166A1 Method for down-regulating osteoprotegerin ligand activity |
| 07/11/2001 | EP1114160A1 Moraxella catarrhalis basb034 polypeptides and uses thereof |
| 07/11/2001 | EP1114159A1 Methods and compositions relating to egf-repeat-containing polypeptides |
| 07/11/2001 | EP1114157A2 Regulatory protein from human keratinocytes |
| 07/11/2001 | EP1114156A2 Mammalian transforming growth factor beta - 9 (ztgfss9) |
| 07/11/2001 | EP1114145A1 Topa |
| 07/11/2001 | EP1113821A1 In situ injection of antigen-presenting cells with genetically enhanced cytokine expression |
| 07/11/2001 | EP1113820A1 Expandible microparticle intracellular delivery system |
| 07/11/2001 | EP1113807A2 Cell mediated gene delivery using muscle derived cells for treating muscle- and bone-related injury or dysfunction |
| 07/11/2001 | EP0969865A4 Mhc class ii antigen-presenting systems and methods for activating cd4?+ t cells |
| 07/11/2001 | EP0731808B1 Nucleosides and oligonucleotides containing boron clusters |
| 07/11/2001 | CN1303442A Method |
| 07/11/2001 | CN1303436A Compositions and methods for sensitizing and inhibiting growth of human tumor cells |
| 07/11/2001 | CN1303298A Gene therapy approaches to supply apolipoprotein A-1 agonists and their use to treat dyslipidemic disorders |
| 07/11/2001 | CN1303276A Drug delivery system comprising tightly compacted solid medicament stock |
| 07/11/2001 | CN1303272A Preparations for application of anti-inflammatory, especially antiseptic agents and/or agents promoting healing of wounds, to upper respiratory tract and/or ear |
| 07/11/2001 | CN1303271A Preparations for application of anti-inflammatory, especially antiseptic agents and/or agents promoting healing of wounds, to lower respiratory tract |
| 07/11/2001 | CN1302886A Polypeptide-human cell wither correlated protein 12 and polynucleotide for coding it |
| 07/11/2001 | CN1302877A Polypeptide-human nuclein II precursor protein 25 and polynucleotide for coding it |
| 07/11/2001 | CN1302664A Gene medicine for treating hemophilia B and its preparing process |
| 07/10/2001 | US6258945 HIV-1P-17 peptide fragments, compositions containing and methods for producing and using same |
| 07/10/2001 | US6258937 Hepadnavirus receptor |
| 07/10/2001 | US6258936 SpoIIIE |
| 07/10/2001 | US6258929 Amino acid sequence of protein which binds presenilin 1; alzheimer's disease |
| 07/10/2001 | US6258791 Enhanced delivery of nucleic acid into humans or animals |
| 07/10/2001 | US6258790 Antisense modulation of integrin α4 expression |
| 07/10/2001 | US6258789 Delivery of gene products by intestinal cell expression |
| 07/10/2001 | US6258788 Induction of protective immune response to tick borne flavivirus proteins |
| 07/10/2001 | US6258787 Treatment of vascular injury |
| 07/10/2001 | US6258600 Antisense modulation of caspase 8 expression |
| 07/10/2001 | US6258596 Variants of apolipoprotein A-I |
| 07/10/2001 | US6258580 Amino acid sequence of adaptor protein required for g protein-dependent activation of phosphatidylinositol-3-kinase; drug screening; diagnosis; antiarthritic agents; antiinflammatory agents; adult respiratory distress syndrome |
| 07/10/2001 | US6258579 I-kappa-b kinase signalsome capable of specifically phosphorylating i-kappa-b-alpha and i-kappa-b-beta; antiinflammatory agents; anticarcinogenic agents; viricides; treatment of autoimmune and nervous system disorders |
| 07/10/2001 | US6258578 His5 |
| 07/10/2001 | US6258557 Nucleotide sequences associated with preferential gene expression; for the treatment of vascular injury; for reducing or preventing the development of arteriosclerosis |
| 07/10/2001 | US6258378 Delivery of biologically active substance to target sites in the body of patients |
| 07/10/2001 | US6258354 Method for homing hematopoietic stem cells to bone marrow stromal cells |
| 07/05/2001 | WO2001048483A2 Method for screening of appetite control agents |
| 07/05/2001 | WO2001048236A1 METHODS FOR IDENTIFYING AGENTS CAPABLE OF MODULATING PROTEIN KINASE C THETA (PKCυ) ACTIVITY |
| 07/05/2001 | WO2001048233A1 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 07/05/2001 | WO2001048232A1 A plasmid for the expression of a therapeutic gene in a tissue |
| 07/05/2001 | WO2001048231A2 Method of achieving persistent transgene expression |
| 07/05/2001 | WO2001048209A2 Genes identified as required for proliferation of e. coli |
| 07/05/2001 | WO2001048208A2 Streptococcus pyogenes virulence genes and proteins and their use |
| 07/05/2001 | WO2001048206A1 A novel polypeptide, a human proteinase suppressor factor 12 and the polynucleotide encoding the polypeptide |
| 07/05/2001 | WO2001048202A1 Mus101 and homologues thereof |
| 07/05/2001 | WO2001048190A2 Therapeutic uses of lna-modified oligonucleotides |
| 07/05/2001 | WO2001048187A2 A molecular switch for regulating mammalian gene expression |
| 07/05/2001 | WO2001048171A1 IDENTIFICATION OF NOVEL SPLICE VARIANTS OF THE HUMAN CATALYTIC SUBUNIT Cβ OF cAMP-DEPENDENT PROTEIN KINASE AND THE USE THEREOF |
| 07/05/2001 | WO2001048170A1 A NOVEL ISOFORM OF HUMAN cAMP-DEPENDENT PROTEIN KINASE, Cα-s, LOCALIZES TO SPERM MIDPIECE AND THE USE THEREOF |
| 07/05/2001 | WO2001048164A2 Modified adenylylcyclase type vi useful in gene therapy for congestive heart failure |
| 07/05/2001 | WO2001048163A2 Dioxygenases catalyzing the asymetric cleavage of beta-carotene |
| 07/05/2001 | WO2001048162A2 Method for the production of vitamin a |
| 07/05/2001 | WO2001048161A2 Human heparanase-related polypeptide and nucleic acid |
| 07/05/2001 | WO2001048007A1 A new polypeptide-clathrin 12 and the polynucleotide encoding it |
| 07/05/2001 | WO2001047986A1 A new polypeptide-thiolase protein 11 and the polynucleotide encoding it |
| 07/05/2001 | WO2001047963A2 Inhibitors of complement activation, their preparation and use |
| 07/05/2001 | WO2001047960A1 Uses of transport proteins for controlling cell cycle |
| 07/05/2001 | WO2001047955A2 Improvements in or relating to immune responses to hiv |
| 07/05/2001 | WO2001047954A2 NOVEL cDNAs ENCODING CATENIN-BINDING PROTEINS WITH FUNCTION IN SIGNALLING AND/OR GENE REGULATION |
| 07/05/2001 | WO2001047953A2 Antibodies against plasma cells |
| 07/05/2001 | WO2001047950A2 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 07/05/2001 | WO2001047946A2 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 07/05/2001 | WO2001047944A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 07/05/2001 | WO2001047942A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 07/05/2001 | WO2001047563A1 Use of lithium (li+) for the preparation of a composition for transfection of a polynucleotide into a cell and compositions useful in gene therapy |
| 07/05/2001 | WO2001047561A1 Hyaluronic acid in the treatment of cancer |
| 07/05/2001 | WO2001047551A2 Eliciting antibodies specific for hepatitis c virus (hcv) |
| 07/05/2001 | WO2001047543A2 Activation and inhibition of the immune system |
| 07/05/2001 | WO2001047510A2 Methods and compositions related to modulators of annexin and cartilage homeostasis |
| 07/05/2001 | WO2001047420A1 Electromagnetic object detector provided with an additional electrode and intended for a medical radiation apparatus |
| 07/05/2001 | WO2001018224A8 Adenoviral vectors modified for increased and persistent expression of the cystic fibrosis transmembrane conductance regulator gene in human airway epithelia |
| 07/05/2001 | WO2001004334A3 Infection with chimaeric adenoviruses of cells negative for the adenovirus serotype 5 coxsacki adenovirus receptor (car) |
| 07/05/2001 | WO2001002019A3 Control of gene expression |
| 07/05/2001 | WO2001000824A3 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 07/05/2001 | WO2001000822A3 Cdna sequences of two interacting fancip2 and fancip3 of the fanconi anemia complementation group a protein |
| 07/05/2001 | WO2000076552A8 Methods and compositions for control of bone formation via modulation of leptin activity |
| 07/05/2001 | WO2000073478A3 Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration |
| 07/05/2001 | WO2000070046A3 Secreted polypeptides and corresponding polynucleotides |
| 07/05/2001 | WO2000069896A3 Molecular interactions in haematopoietic cells |